Séminaire de recherche PACRI - N°33 - 29.05.2026

Value of the Information & Strength of the Argument

The first presentation provides a rigorous modeling approach, with clear assumptions, calibration on French data, and sensitivity to uncertainty. The argumentation is solid, though the presentation is concise and some details are omitted. The second presentation offers a well-structured policy analysis, synthesizing multiple sources and personal observations. The argumentation is persuasive, but it relies on qualitative evidence and may lack quantitative depth. Both presentations are valuable for their respective fields.

Scientific Rigor, Source Quality, Title Accuracy

The first presentation uses French surveillance data and expert input, but specific sources are not cited in the video. The second presentation cites key documents such as the Global Monitoring Board report, WHO Global Influenza Strategy, and a paper on COVID-19 responses. The title accurately reflects the seminar content. The Q&A reveals some limitations, such as the model not considering individual-level effects and the policy analysis being for a non-scientific audience.

The title accurately reflects the content: a research seminar with two presentations on pneumococcal vaccination modeling and pandemic preparedness.

7/10

The seminar presents two research projects with clear methodologies: a mathematical model for pneumococcal vaccination and a policy analysis on pandemic preparedness. The modeling work is detailed and calibrated on French data, but the presentation is a seminar format with limited peer review. The policy analysis relies on qualitative synthesis of official documents and personal observation, which is appropriate but less rigorous than a systematic review.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 02:00Introduction to pneumococcal carriage and disease burden.
• 05:00Overview of pneumococcal vaccines and their impact.
• 10:00Description of the mathematical model structure.
• 15:00Calibration of the model on French data.
• 20:00Presentation of vaccination scenarios and results.
• 25:00Discussion of limitations and future cost-effectiveness analysis.
• 30:00Second presentation: pandemic preparedness political momentum.
• 35:00Analysis of crisis cycle and structural fragilities.
• 40:00Recommendations for strengthening preparedness.
• 45:00Q&A session with audience questions.

• Global Monitoring Board report — Cited by Mary Andrews as an assessment of global preparedness across 30 indicators.
• WHO Global Influenza Strategy — Cited by Mary Andrews as a normative policy framework.
• Paper reviewing 28 countries' COVID-19 response — Cited by Mary Andrews for crisis management analysis.
• WHO Pandemic Agreement — Cited by Mary Andrews as a key governance document.
• HERA (Health Emergency Preparedness and Response Authority) — Cited by Mary Andrews in the context of EU governance.

• WHO Global Influenza Strategy — Supports the need for sustained preparedness efforts.
• Global Monitoring Board report — Highlights gaps in global preparedness.

• Potential counterarguments on vaccine effectiveness — The model assumes certain vaccine efficacy levels that may be debated; the Q&A mentions waning immunity and serotype replacement as uncertainties.